Greenrise Global Brands Inc.'s announced the launch of a new dronabinol medical cannabis product available in pharmacies beginning in January 2022. Dronabinol is pure Tetrahydrocannabinol (THC) and is registered as an active pharmaceutical ingredient (API). AMP's dronabinol product is "Made in Germany." It will be offered at a competitive price and completes AMP's product portfolio supporting any therapy requiring medicinal cannabis products for the growing range of therapies approaches being prescribed by a growing number of doctors. Dronabinol has been a prominent medical cannabis product in Germany for many years, and it is frequently prescribed by doctors for pain management. In comparison to the procedure of preparing vaporized forms of medicinal cannabis, many patients find dronabinol prescriptions easier to ingest. Doctors believe that the THC concentration of dronabinol is more accurate than that of flowers or extracts, making dosage monitoring easier. Pharmacists use Dronabinol to fill doctor-prescribed medicine prescriptions for patients, usually in the form of drops or solutions.